| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.096 | 0.09 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.09 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.09 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |